Skip To Main Content
Lily Olayinka on Muck Rack

Lily Olayinka

As seen in: Wiley Online Library, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lily

Contact Lily, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

"SARS-CoV-2 Anti-Spike Antibodies After Vaccination in Pediatric Heart " by Joseph A Spinner, Christopher L Julien et al.

|
By Joseph A. Spinner, Christopher Julien, Lily Olayinka, William J Dreyer
| Texas Medical Center
BACKGROUND: BACKGROUND: There is a paucity of data regarding the antibody response to SARS-CoV-2 vaccination in children after solid organ transplant. METHODS: We retrospectively reviewed the SARS-CoV-2 Anti-Spike IgG antibodies measured following SARS-CoV-2 vaccination at our pediatric heart transplant (HTx) center.
Open in Who Shared Issue with article?

"Comparison of Random Urine Protein/Creatinine Ratio With 24-Hour Urine" by Lily Olayinka, Emily Garnett et al.

|
By Lily Olayinka, Emily O. Garnett, Brian D. Burnett, Sridevi Devaraj
| Texas Medical Center
Keywords Pre-eclampsia, Protein-creatinine-ratio, Proteinuria, 24-H urine protein excretion Abstract INTRODUCTION: Proteinuria is one of the classical criteria for the diagnosis of pre-eclampsia. The gold standard remains the measurement of 24-h urine protein which is time consuming and prone to preanalytical errors. Random urine protein creatinine ratio (UPCR) is endorsed by clinical practice guidelines as a faster alternative.
Open in Who Shared Issue with article?

Validation of Atovaquone Plasma Levels by Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring in Pediatric Patients

|
By Thomas Horvath, Izmarie Poventud-Fuentes, Lily Olayinka, Asha James
| Texas Medical Center
BACKGROUND: Atovaquone has traditionally been used as an antiparasitic and antifungal agent, but recent studies have shown its potential as an anticancer agent. The high variability in atovaquone bioavailability highlights the need for therapeutic drug monitoring, especially in pediatric patients. The goal of our study was to develop and validate the performance of an assay to quantify atovaquone plasma concentrations collected from pediatric cancer patients using LC-MS/MS.
Open in Who Shared Issue with article?
See all 5 articles